Evan is a research fellow at the Kirby Institute in Sydney whose research focusses on addressing the remaining barriers to HCV elimination.

Laura is a Medical Scientist at the Victorian Infectious Diseases Reference Laboratory in Melbourne. She has recently completed her PhD where she optimised the CRISPR-Cas13b system to target hepatitis B RNAs to reduce HBV replication as a potential novel therapy for HBV.

Chris is a postdoctoral mathematical modeller working at the Burnet Institute. His primary research focus is the use of mathematical models to eliminate hepatitis B as a public health threat.

Rodney Guzman is a clinical research nurse with a ten-year career spanning surgical nursing, neuroscience research and community health.

Shane Tillakeratne is a PhD student and data manager working on evaluating viral hepatitis treatments for marginalized communities in Australia, utilising various health records and information to better understand if treatments are reaching and effectively helping those who need them most.